Skip to content

Info-AF Information Preferences in Patients With Atrial Fibrillation/Flutter and the Association With Clinical Symptoms

Info-AF Information Preferences in Patients With Atrial Fibrillation/Flutter and the Association With Clinical Symptoms

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04299269
Enrollment
130
Registered
2020-03-06
Start date
2020-02-28
Completion date
2023-02-28
Last updated
2022-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Brief summary

The aim of this project is to identify a variable that discerns patients who are interested in their disease (atrial fibrillation/atrial flutter) from patients who show no interest and furthermore test this theory in a questionnaire survey. This should help distinguish between patients who are interested in shared decision making and patients who are not (further projects planned).

Interventions

OTHERQuestionnaire

Questionnaire including questions about Quality of life, symptoms and general informations

Sponsors

Medical University of Vienna
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Current atrial fibrillation/flutter * \>18 years of age * sufficient knowledge of the german language to fill out the questionnaire

Exclusion criteria

* \< 18 years of age * insufficient knowledge of the german language to fill out the questionnaire * Hemodynamic instability

Design outcomes

Primary

MeasureTime frameDescription
Preferences for autonomy measured with questionnairethrough study completion, an average of 1 yearPotential predictors of the outcome are clinical symptoms. Additional covariables will be patient characteristics including age and gender and disease characteristics. Regression analysis will be used as the main statistical method. Descriptive statistics and graphs and inferential statistics will be used as appropriate.

Countries

Austria

Contacts

Primary ContactNikola Schütz, Dr.med.univ.
nikola.schuetz@meduniwien.ac.at004314040019640

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026